ADHD TREATMENT: FROM MEDICATION TO BEHAVIORAL THERAPIES- A SYSTEMATIC REVIEW

Keywords: ADHD, Stimulants, ADHD Therapy, ADHD treatment

Abstract

Introduction: Nowadays, ADHD is one of the most common diagnoses in the mental health field. It presents a wide spectrum of clinical presentations that affect patients’ everyday life. Variety of symptoms make each patients’ needs individual, and because of that, treatment of ADHD must be adjusted to each person separately to achieve the best possible outcome.

Materials and methods: This article, based on a PubMed review of available research, examines ADHD treatment

Key findings and conclusions: Options in first line medications are limited, therefore formulation technologies are one of the few methods to modify the therapy. Alternative to that, especially for patients that cannot take stimulants, are non-stimulant medications generally used in other medical fields. Additionally, psychotherapy is inherent for patients to understand their disorder, which allows them to accept it. The aim of this article is to present the basis of a complex issue, as ADHD treatment is.

References

Olagunju, A. E., & Ghoddusi, F. (2024). Attention-Deficit/Hyperactivity Disorder in Adults. American family physician, 110(2), 157–166.

Danielson, M. L., Claussen, A. H., Bitsko, R. H., Katz, S. M., Newsome, K., Blumberg, S. J., Kogan, M. D., & Ghandour, R. (2024). ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment. Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 53(3), 343–360. https://doi.org/10.1080/15374416.2024.2335625

Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L., & Alati, R. (2023). The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. Journal of affective disorders, 339, 860–866. https://doi.org/10.1016/j.jad.2023.07.071

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., Atwoli, L., … Wang, Y. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience and biobehavioral reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022

Cénat, J. M., Blais-Rochette, C., Morse, C., Vandette, M. P., Noorishad, P. G., Kogan, C., Ndengeyingoma, A., & Labelle, P. R. (2021). Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals: A Systematic Review and Meta-analysis. JAMA psychiatry, 78(1), 21–28. https://doi.org/10.1001/jamapsychiatry.2020.2788

Cénat, J. M., Kokou-Kpolou, C. K., Blais-Rochette, C., Morse, C., Vandette, M. P., Dalexis, R. D., Darius, W. P., Noorishad, P. G., Labelle, P. R., & Kogan, C. S. (2024). Prevalence of ADHD among Black Youth Compared to White, Latino and Asian Youth: A Meta-Analysis. Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 53(3), 373–388. https://doi.org/10.1080/15374416.2022.2051524

Cutler, A. J., & Hanaie, J. (2025). Understanding the delivery technology used in ADHD stimulant medications can help to individualize treatment. CNS spectrums, 30(1), e30. https://doi.org/10.1017/S1092852925000070

Oliva, H. N. P., Prudente, T. P., Mayerson, T. F., Mignosa, M. M., Oliva, I. O., Potenza, M. N., Jegede, O. O., & Angarita, G. A. (2025). Safety of Stimulants Across Patient Populations: A Meta-Analysis. JAMA network open, 8(5), e259492. https://doi.org/10.1001/jamanetworkopen.2025.9492

Radonjić, N. V., Bellato, A., Khoury, N. M., Cortese, S., & Faraone, S. V. (2023). Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis. CNS drugs, 37(5), 381–397. https://doi.org/10.1007/s40263-023-01005-8

Isfandnia, F., El Masri, S., Radua, J., & Rubia, K. (2024). The effects of chronic administration of stimulant and non-stimulant medications on executive functions in ADHD: A systematic review and meta-analysis. Neuroscience and biobehavioral reviews, 162, 105703. https://doi.org/10.1016/j.neubiorev.2024.105703

Yu, S., Shen, S., & Tao, M. (2023). Guanfacine for the Treatment of Attention-Deficit Hyperactivity Disorder: An Updated Systematic Review and Meta-Analysis. Journal of child and adolescent psychopharmacology, 33(2), 40–50. https://doi.org/10.1089/cap.2022.0038

Newcorn, J. H., Krone, B., & Dittmann, R. W. (2022). Nonstimulant Treatments for ADHD. Child and adolescent psychiatric clinics of North America, 31(3), 417–435. https://doi.org/10.1016/j.chc.2022.03.005

Vilus, J. T., & Engelhard, C. (2025). Nonstimulant Medications for Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatric annals, 54(1), e27–e33. https://doi.org/10.3928/19382359-20241007-07

Mather, K., & Condren, M. (2022). Extended-Release Viloxazine for Children and Adolescents With Attention Deficit Hyperactivity Disorder. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 27(5), 409–414. https://doi.org/10.5863/1551-6776-27.5.409

Strålin, E. E., Thorell, L. B., Lundgren, T., Bölte, S., & Bohman, B. (2025). Cognitive behavioral therapy for ADHD predominantly inattentive presentation: randomized controlled trial of two psychological treatments. Frontiers in psychiatry, 16, 1564506. https://doi.org/10.3389/fpsyt.2025.1564506

DuPaul, G. J., Weyandt, L. L., O'Dell, S. M., & Varejao, M. (2009). College students with ADHD: current status and future directions. Journal of attention disorders, 13(3), 234–250. https://doi.org/10.1177/1087054709340650

Retz, W., Stieglitz, R. D., Corbisiero, S., Retz-Junginger, P., & Rösler, M. (2012). Emotional dysregulation in adult ADHD: What is the empirical evidence?. Expert review of neurotherapeutics, 12(10), 1241–1251. https://doi.org/10.1586/ern.12.109

Adamou, M., Arif, M., Asherson, P., Aw, T. C., Bolea, B., Coghill, D., Guðjónsson, G., Halmøy, A., Hodgkins, P., Müller, U., Pitts, M., Trakoli, A., Williams, N., & Young, S. (2013). Occupational issues of adults with ADHD. BMC psychiatry, 13, 59. https://doi.org/10.1186/1471-244X-13-59

Yang, X., Zhang, L., Yu, J., & Wang, M. (2025). Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis. Frontiers in psychiatry, 16, 1516878. https://doi.org/10.3389/fpsyt.2025.1516878

Champ, R. E., Adamou, M., & Tolchard, B. (2021). The impact of psychological theory on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults: A scoping review. PloS one, 16(12), e0261247. https://doi.org/10.1371/journal.pone.0261247

Nimmo-Smith, V., Merwood, A., Hank, D., Brandling, J., Greenwood, R., Skinner, L., Law, S., Patel, V., & Rai, D. (2020). Non-pharmacological interventions for adult ADHD: a systematic review. Psychological medicine, 50(4), 529–541. https://doi.org/10.1017/S0033291720000069

López-Pinar, C., Martínez-Sanchís, S., Carbonell-Vayà, E., Martínez-Raga, J., & Retz, W. (2024). Formulation-based cognitive behavioral therapy compared to an active control and a waitlist in adult inmates with ADHD: study protocol for a randomized controlled trial. Trials, 25(1), 594. https://doi.org/10.1186/s13063-024-08434-w

Santamaría-Vázquez, E., Estudillo-Guerra, A., Ali, L., Martinez, D., Hornero, R., & Morales-Quezada, L. (2025). Effects of a novel non-pharmacological intervention based on respiratory biofeedback, neurofeedback and median nerve stimulation to treat children with ADHD. Frontiers in human neuroscience, 19, 1478501. https://doi.org/10.3389/fnhum.2025.1478501

Yang, X., Zhang, L., Yu, J., & Wang, M. (2025). Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis. Frontiers in psychiatry, 16, 1516878. https://doi.org/10.3389/fpsyt.2025.1516878

Research consortium for non-pharmacological interventions on ADHD, Dentz, A., Soelch, C. M., Fahim, C., Torsello, A., Parent, V., Ponsioen, A., Guay, M. C., Bioulac-Rogier, S., Clément, C., Bader, M., & Romo, L. (2024). Non-pharmacological treatment of Attention Deficit Disorder with or without Hyperactivity (ADHD). Overview and report of the first international symposium on the non-pharmacological management of ADHD. L'Encephale, 50(3), 309–328. https://doi.org/10.1016/j.encep.2023.04.010

Views:

19

Downloads:

11

Published
2025-09-30
Citations
How to Cite
Barbara Madoń, Agnieszka Brzezińska, Maciej Dudziński, Wojciech Gąska, Izabela Lekan, Michał Lenart, Joanna Mazurek, Ignacy Rożek, Barbara Teresińska, & Weronika Tuszyńska. (2025). ADHD TREATMENT: FROM MEDICATION TO BEHAVIORAL THERAPIES- A SYSTEMATIC REVIEW. International Journal of Innovative Technologies in Social Science, 5(3(47). https://doi.org/10.31435/ijitss.3(47).2025.3928

Most read articles by the same author(s)

1 2 > >>